Global Oncology Based Molecular Diagnostic Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Oncology Based Molecular Diagnostic Revenue
• 1.4 Market by Type
  • 1.4.1 Global Oncology Based Molecular Diagnostic Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Instruments
  • 1.4.3 Reagents
• 1.5 Market by Application
  • 1.5.1 Global Oncology Based Molecular Diagnostic Market Share by Application: 2020 VS 2026
  • 1.5.2 Breast Cancer
  • 1.5.3 Prostate Cancer
  • 1.5.4 Colorectal Cancer
  • 1.5.5 Cervical Cancer
  • 1.5.6 Liver Cancer
  • 1.5.7 Lung Cancer
  • 1.5.8 Blood Cancer
  • 1.5.9 Kidney Cancer
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Oncology Based Molecular Diagnostic Market Perspective (2015-2026)
• 2.2 Global Oncology Based Molecular Diagnostic Growth Trends by Regions
  • 2.2.1 Oncology Based Molecular Diagnostic Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Oncology Based Molecular Diagnostic Historic Market Share by Regions (2015-2020)
  • 2.2.3 Oncology Based Molecular Diagnostic Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Oncology Based Molecular Diagnostic Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Oncology Based Molecular Diagnostic Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Oncology Based Molecular Diagnostic Players by Market Size
  • 3.1.1 Global Top Oncology Based Molecular Diagnostic Players by Revenue (2015-2020)
  • 3.1.2 Global Oncology Based Molecular Diagnostic Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Oncology Based Molecular Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Oncology Based Molecular Diagnostic Market Concentration Ratio
  • 3.2.1 Global Oncology Based Molecular Diagnostic Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Oncology Based Molecular Diagnostic Revenue in 2019
• 3.3 Oncology Based Molecular Diagnostic Key Players Head office and Area Served
• 3.4 Key Players Oncology Based Molecular Diagnostic Product Solution and Service
• 3.5 Date of Enter into Oncology Based Molecular Diagnostic Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Oncology Based Molecular Diagnostic Historic Market Size by Type (2015-2020)
• 4.2 Global Oncology Based Molecular Diagnostic Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Oncology Based Molecular Diagnostic Market Size by Application (2015-2020)
• 5.2 Global Oncology Based Molecular Diagnostic Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Oncology Based Molecular Diagnostic Market Size (2015-2020)
• 6.2 Oncology Based Molecular Diagnostic Key Players in North America (2019-2020)
• 6.3 North America Oncology Based Molecular Diagnostic Market Size by Type (2015-2020)
• 6.4 North America Oncology Based Molecular Diagnostic Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Oncology Based Molecular Diagnostic Market Size (2015-2020)
• 7.2 Oncology Based Molecular Diagnostic Key Players in Europe (2019-2020)
• 7.3 Europe Oncology Based Molecular Diagnostic Market Size by Type (2015-2020)
• 7.4 Europe Oncology Based Molecular Diagnostic Market Size by Application (2015-2020)

8 China

• 8.1 China Oncology Based Molecular Diagnostic Market Size (2015-2020)
• 8.2 Oncology Based Molecular Diagnostic Key Players in China (2019-2020)
• 8.3 China Oncology Based Molecular Diagnostic Market Size by Type (2015-2020)
• 8.4 China Oncology Based Molecular Diagnostic Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Oncology Based Molecular Diagnostic Market Size (2015-2020)
• 9.2 Oncology Based Molecular Diagnostic Key Players in Japan (2019-2020)
• 9.3 Japan Oncology Based Molecular Diagnostic Market Size by Type (2015-2020)
• 9.4 Japan Oncology Based Molecular Diagnostic Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Oncology Based Molecular Diagnostic Market Size (2015-2020)
• 10.2 Oncology Based Molecular Diagnostic Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Oncology Based Molecular Diagnostic Market Size by Type (2015-2020)
• 10.4 Southeast Asia Oncology Based Molecular Diagnostic Market Size by Application (2015-2020)

11 India

• 11.1 India Oncology Based Molecular Diagnostic Market Size (2015-2020)
• 11.2 Oncology Based Molecular Diagnostic Key Players in India (2019-2020)
• 11.3 India Oncology Based Molecular Diagnostic Market Size by Type (2015-2020)
• 11.4 India Oncology Based Molecular Diagnostic Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Oncology Based Molecular Diagnostic Market Size (2015-2020)
• 12.2 Oncology Based Molecular Diagnostic Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Oncology Based Molecular Diagnostic Market Size by Type (2015-2020)
• 12.4 Central & South America Oncology Based Molecular Diagnostic Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Abbott Laboratories
  • 13.1.1 Abbott Laboratories Company Details
  • 13.1.2 Abbott Laboratories Business Overview
  • 13.1.3 Abbott Laboratories Oncology Based Molecular Diagnostic Introduction
  • 13.1.4 Abbott Laboratories Revenue in Oncology Based Molecular Diagnostic Business (2015-2020))
  • 13.1.5 Abbott Laboratories Recent Development
• 13.2 Bayer Healthcare
  • 13.2.1 Bayer Healthcare Company Details
  • 13.2.2 Bayer Healthcare Business Overview
  • 13.2.3 Bayer Healthcare Oncology Based Molecular Diagnostic Introduction
  • 13.2.4 Bayer Healthcare Revenue in Oncology Based Molecular Diagnostic Business (2015-2020)
  • 13.2.5 Bayer Healthcare Recent Development
• 13.3 Beckton Dickinson
  • 13.3.1 Beckton Dickinson Company Details
  • 13.3.2 Beckton Dickinson Business Overview
  • 13.3.3 Beckton Dickinson Oncology Based Molecular Diagnostic Introduction
  • 13.3.4 Beckton Dickinson Revenue in Oncology Based Molecular Diagnostic Business (2015-2020)
  • 13.3.5 Beckton Dickinson Recent Development
• 13.4 Cepheid
  • 13.4.1 Cepheid Company Details
  • 13.4.2 Cepheid Business Overview
  • 13.4.3 Cepheid Oncology Based Molecular Diagnostic Introduction
  • 13.4.4 Cepheid Revenue in Oncology Based Molecular Diagnostic Business (2015-2020)
  • 13.4.5 Cepheid Recent Development
• 13.5 Dako
  • 13.5.1 Dako Company Details
  • 13.5.2 Dako Business Overview
  • 13.5.3 Dako Oncology Based Molecular Diagnostic Introduction
  • 13.5.4 Dako Revenue in Oncology Based Molecular Diagnostic Business (2015-2020)
  • 13.5.5 Dako Recent Development
• 13.6 Danaher Corporation
  • 13.6.1 Danaher Corporation Company Details
  • 13.6.2 Danaher Corporation Business Overview
  • 13.6.3 Danaher Corporation Oncology Based Molecular Diagnostic Introduction
  • 13.6.4 Danaher Corporation Revenue in Oncology Based Molecular Diagnostic Business (2015-2020)
  • 13.6.5 Danaher Corporation Recent Development
• 13.7 Gen Probe
  • 13.7.1 Gen Probe Company Details
  • 13.7.2 Gen Probe Business Overview
  • 13.7.3 Gen Probe Oncology Based Molecular Diagnostic Introduction
  • 13.7.4 Gen Probe Revenue in Oncology Based Molecular Diagnostic Business (2015-2020)
  • 13.7.5 Gen Probe Recent Development
• 13.8 Qiagen
  • 13.8.1 Qiagen Company Details
  • 13.8.2 Qiagen Business Overview
  • 13.8.3 Qiagen Oncology Based Molecular Diagnostic Introduction
  • 13.8.4 Qiagen Revenue in Oncology Based Molecular Diagnostic Business (2015-2020)
  • 13.8.5 Qiagen Recent Development
• 13.9 Roche Diagnostics
  • 13.9.1 Roche Diagnostics Company Details
  • 13.9.2 Roche Diagnostics Business Overview
  • 13.9.3 Roche Diagnostics Oncology Based Molecular Diagnostic Introduction
  • 13.9.4 Roche Diagnostics Revenue in Oncology Based Molecular Diagnostic Business (2015-2020)
  • 13.9.5 Roche Diagnostics Recent Development
• 13.10 Siemens Healthineers
  • 13.10.1 Siemens Healthineers Company Details
  • 13.10.2 Siemens Healthineers Business Overview
  • 13.10.3 Siemens Healthineers Oncology Based Molecular Diagnostic Introduction
  • 13.10.4 Siemens Healthineers Revenue in Oncology Based Molecular Diagnostic Business (2015-2020)
  • 13.10.5 Siemens Healthineers Recent Development
• 13.11 Sysmex Corporation
  • 10.11.1 Sysmex Corporation Company Details
  • 10.11.2 Sysmex Corporation Business Overview
  • 10.11.3 Sysmex Corporation Oncology Based Molecular Diagnostic Introduction
  • 10.11.4 Sysmex Corporation Revenue in Oncology Based Molecular Diagnostic Business (2015-2020)
  • 10.11.5 Sysmex Corporation Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer